A legacy of impact
Our scientists have created a therapy against the Ebola virus, discovered an early diagnostic for breast cancer and provided data that brought potentially harmful chemicals in personal-care products to light.
As the premier scientific research institute in the nation’s fastest-growing research university, Biodesign’s impact is accelerating. These are just a handful of ways our research is answering today’s challenges.
|By 2023, Biodesign’s estimated annual impact on Arizona’s economy will reach $2.9 billion.|
|Biodesign has attracted over $760 million in funding from grants as well as philanthropic and industry sources.|
|Scientists at Biodesign are undertaking research in over 200 active research projects.|
Clinical Testing Laboratory
When COVID-19 appeared in Arizona, we sprang into action to protect our community. Biodesign’s Clinical Testing Lab created the first saliva-based COVID-19 PCR test publicly available in the U.S. Today, the lab tracks critical COVID-19 trends and partners with the state to provide public testing.
Spotlight: The brain
Commonly used herbicide crosses blood-brain barrier
A broad-spectrum herbicide applied to agricultural crops around the world is shown for the first time to cross the blood-brain barrier and infiltrate the brain.
Gifted students explore brain science during an 8-week intensive program
The ASU-Banner Neuroscience Scholars Program provided hands-on training experience for high-achieving students in neuroscience and neurodegenerative research.
ASU scientists find molecular clues behind traumatic brain injury
New research has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known as traumatic brain injury.